美国食品药品管理局(FDA)已批准他汀类降胆固醇药的安全性标签的重要更改。这次标签更改系根据FDA对于他汀类药物的综述,为公众提供了更多的关于他汀类药物安全与有效使用的信息。标签更改的内容包括以下几点:?监测肝酶 The U.S. Food and Drug Administration (FDA) has approved important changes to the safety label for statin-lowering cholesterol drugs. This labeling change is based on the FDA review of statins and provides the public with more information about the safe and effective use of statins. Changes to the label include the following: • Monitoring of liver enzymes